Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med. 2014 Aug; 174(8):1301-7.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.